Ocular immune privilege: therapeutic opportunities from an experiment of nature
The DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the vitreous space, there are higher chances of exposure to systemic circulation,15 whereas the subretinal space does not expose AAV to systemic circulation, owing to the blood-retina barrier.9,33”
From Systemic and local immune responses to intraocular AAV vector administration in non-human primates (2022) · cites this paper as [9]
In the citing paper
“Idebenone (Raxone), a synthetic analogue of coenzyme Q10, has been used by practitioners in the European Union albeit with controversial efficacy, because results from a phase 3 study were not statistically different from placebo.11”
In the citing paper
“The eye was historically considered to be an immune privileged site, as a result of several features. These include the blood-retinal barrier formed by tight junctions between endothelial and retinal pigmented epithelium cells as well as in retinal vessels, the lack of anatomically defined lymphatic drainage and an intraocular anti-inflammatory and immunomodulatory micro-environment [43].”
From Characterization of anti-AAV2 neutralizing antibody levels in sheep prior to and following intravitreal AAV2.7m8 injection (2024) · cites this paper as [43]
In the citing paper
“Additionally, there are lower risks of immunogenicity when targeting AAV vectors towards relatively immune-privileged sites, such as the subretinal space and the cochlea [93,94].”
From Circumventing the packaging limit of AAV-mediated gene replacement therapy for neurological disorders (2022) · cites this paper as [93]
Citations
Cites
Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., & Ferguson, T. A. (1995) · Science · doi:10.1126/science.270.5239.1189 · Cited by 2,005 · cited 1×
“CD95L, which is expressed constitutively by cells of the eye (and other immune-privileged tissues), is partially responsible for acceptance of orthotopic corneal allografts, and for making the cornea and retinal pigment epithelium immune-privileged tissue”
BackgroundMedawar, P. B. (1948) · PubMed · Cited by 1,109
Immunologically Privileged Sites
Barker, C. F., & Billingham, R. E. (1978) · Advances in Immunology · doi:10.1016/s0065-2776(08)60930-x · Cited by 815
PD-1:PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2
Carter, L. L., Fouser, L. A., Jussif, J., Fitz, L., Deng, B., Wood, C. R., Collins, M., Honjo, T., Freeman, G. J., & Carreno, B. M. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200203)32:3<634::aid-immu634>3.0.co;2-9 · Cited by 673
Immunobiology of Tissue Transplantation: A Return to the Passenger Leukocyte Concept
Laffery, K. J., Prowse, S. J., Simeonovic, C. J., & Warren, H. S. (1983) · Annual Review of Immunology · doi:10.1146/annurev.iy.01.040183.001043 · Cited by 509
Suda, T., Hashimoto, H., Tanaka, M., Ochi, T., & Nagata, S. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.12.2045 · Cited by 508 · cited 1×
“Attempts to achieve this goal with CD95L have already been made and the results are mixe”
ResultIdentification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor.
Cousins, S. W., McCabe, M. M., Danielpour, D., & Streilein, J. W. (1991) · PubMed · Cited by 477
Self-citationKang, S.-M., Schneider, D. B., Lin, Z., Hanahan, D., Dichek, D. A., Stock, P. G., & Baekkeskov, S. (1997) · Nature Medicine · doi:10.1038/nm0797-738 · Cited by 450 · cited 1×
“First, conventional immune-recognition pathways can be interrupted by providing allografts with healthy corneal epithelium, or factors derived from this tissue that suppress lymphangiogenesis and attendant inflammatio”
BackgroundSo, K.-F., & Aguayo, A. J. (1985) · Brain Research · doi:10.1016/0006-8993(85)91047-9 · Cited by 390
CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival.
Stuart, P. M., Griffith, T. S., Usui, N., Pepose, J., Yu, X., & Ferguson, T. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119173 · Cited by 367 · cited 1×
“CD95L, which is expressed constitutively by cells of the eye (and other immune-privileged tissues), is partially responsible for acceptance of orthotopic corneal allografts, and for making the cornea and retinal pigment epithelium immune-privileged tissue”
Background
Research works printed but not linked: 5
- Haskova, Z., Arancibia-Carcamo, C. V., Christianson, G. J., Roopenian, D. C. & Ksander, B. R. in Uveitis in the Third Millenium (eds Dodds, E. M. & Couto, C. A.) 7–10 (Elsevier Science, Amsterdam, 2000).
- Sano, Y., Ksander, B. R. & Streilein, J. W. Fate of orthotopic corneal allografts in eyes that cannot support ACAID induction. Invest. Ophthalmol. Vis. Sci. 36, 2176–2185 (1995). This paper shows how immune privilege in the eye is disrupted by experimental manipulations of the cornea.
- Bora, H. S. et al. in Advances in Ocular Imunolology (eds Nussenblatt, R. B., Whitcup, S. M., Caspi, R. R. & Gery, I.) 83–86 (Amsterdam, Elsevier, 1994).
- Hori, J. & Streilein, J. W. Role of recipient epithelium in promoting survival of orthotopic corneal allografts in mice. Invest. Ophthalmol. Vis. Sci. 42, 720–726 (2001).
- Ishida, K., Panjwani, N., Cao, Z. & Streilein, J. W. Participation of pigment epithelium in ocular immune privilege. 3. Galectin-1 contributes to immunosuppressive properties of retinal pigment epithelium. Ocular Immun. Inflamm. (in the press).
Cited by
Items 401–500 of 806
Watte, C. M., Nakamura, T., Lau, C. H., Ortaldo, J. R., & Stein‐Streilein, J. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0807579 · Cited by 19
“)-associated immune deviation (ACAID) [9]}, antigen is picked up by the indigenous F4/80 APC within the a.”
BackgroundAlfaar, A. S., Stürzbecher, L., Diedrichs‐Möhring, M., Lam, M., Roubeix, C., Ritter, J. M., Schumann, K., Annamalai, B., Pompös, I.-M., Rohrer, B., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02620-w · Cited by 19
Burlingham, W. J., & Bénichou, G. (2012) · Chimerism · doi:10.4161/chim.21668 · Cited by 18
Intact Calibers of Retinal Vessels in Patients with Systemic Sclerosis
Aissopou, E. K., Bournia, V.-K., Protogerou, A. D., Panopoulos, S., Papaioannou, T., Vlachoyiannopoulos, P. G., Matucci‐Cerinic, M., & Sfikakis, P. P. (2015) · The Journal of Rheumatology · doi:10.3899/jrheum.141425 · Cited by 18
Horie, S., Sugita, S., Futagami, Y., Kawaguchi, T., Kamoi, K., Shirato, S., & Mochizuki, M. (2009) · Experimental Eye Research · doi:10.1016/j.exer.2009.01.011 · Cited by 18
Early Subretinal Allograft Rejection is Characterized by Innate Immune Activity
Kennelly, K. P., Holmes, T. M., Wallace, D., O’Farrelly, C., & Keegan, D. (2017) · Cell Transplantation · doi:10.3727/096368917x694697 · Cited by 20
Yoon, C. H., Choi, S. H., Choi, H. J., Lee, H. J., Kang, H. J., Kim, J. M., Park, C., Choi, K., Kim, H., Ahn, C., et al. (2019) · Xenotransplantation · doi:10.1111/xen.12559 · Cited by 18
Le, V. N. H., Hou, Y., Bock, F., & Cursiefen, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-60705-z · Cited by 18
Rao, R. C., Arduini, B. L., Borden, S., Sareen, D., Svendsen, C. N., Lee, P. P., Ryan, C. J., Kodati, S., Nyaiburi, C., Wolsieffer, K., et al. (2025) · Cell stem cell · doi:10.1016/j.stem.2025.08.012 · Cited by 19
“65 After immune suppression was stopped, there was no evidence of rejection.”
Targeted delivery of genome editors in vivo
Ngo, W., Wu, J. L. Y., Wasko, K. M., & Doudna, J. A. (2026) · Nature Biotechnology · doi:10.1038/s41587-025-02945-w · Cited by 22
“The eyes are immuno-privileged organs with specialized barriers that reduce the immune response to preserve vision 21 .”
Kusuhara, S., Kim, K. W., Miki, A., & Nakamura, M. (2022) · American Journal of Ophthalmology Case Reports · doi:10.1016/j.ajoc.2022.101521 · Cited by 17
The small tellurium-based compound SAS suppresses inflammation in human retinal pigment epithelium.
Dardik, R., Livnat, T., Halpert, G., Jawad, S., Nisgav, Y., Azar-Avivi, S., Liu, B., Nussenblatt, R. B., Weinberger, D., & Sredni, B. (2016) · PubMed Central · Cited by 18
Role of Endogenous Regulators of Hem- And Lymphangiogenesis in Corneal Transplantation
Clahsen, T., Büttner, C., Hatami, N., Reis, A., & Cursiefen, C. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020479 · Cited by 19
“In contrast, grafts, implanted into pathologically prevascularized murine corneal recipient beds (high-risk keratoplasty) (Figure 1), are rejected in more than 50% of transplantations despite immunosuppressive therapy [4,5].”
BackgroundDifferential Activation of Immune Cells for Genetically Different Decellularized Cardiac Tissues
Methe, K., Nayakawde, N. B., Banerjee, D., Sihlbom, C., Agbajogu, C., Travnikova, G., & Olausson, M. (2020) · Tissue Engineering Part A · doi:10.1089/ten.tea.2020.0055 · Cited by 16
“14 In this regard, the approach toward biomaterials has changed from immune evasiveness to immune instructiveness.”
Edo, A., Sugita, S., Futatsugi, Y., Sho, J., Onishi, A., Kiuchi, Y., & Takahashi, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217831 · Cited by 18
“This is also because iPSC-RGC transplantation is characterized by an unbroken blood retinal barrier and less systemic blood flow into the eye if the host RPE is not compromised or if no retinal hemorrhage occurs [49].”
BackgroundReichenbach, A., & Bringmann, A. (2015) · Colloquium Series on Neuroglia in Biology and Medicine From Physiology to Disease · doi:10.4199/c00122ed1v01y201412ngl003 · Cited by 20
Rao, R. C., & Zacks, D. N. (2014) · Developments in ophthalmology · doi:10.1159/000357376 · Cited by 20
Dace, D. S., Chen, P. W., & Niederkorn, J. Y. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.10.6115 · Cited by 22
Lü, B., Lin, Y., Tsai, Y.-C., Girman, S., Adamus, G., Jones, M. K., Shelley, B., Svendsen, C. N., & Wang, S. (2015) · Translational Vision Science & Technology · doi:10.1167/tvst.4.1.7 · Cited by 16
“immunosuppressive factors, and activation of some immunoregulatory T cells.(29,53) This property of immune privilege in the eye is beneficial for cell transplantation.”
BackgroundRetinal Pigment Epithelial Cells Induce foxp3 + Regulatory T Cells via Membrane-bound TGF-β
Vega, J. L., Saban, D. R., Carrier, Y., Masli, S., & Weiner, H. L. (2010) · Ocular Immunology and Inflammation · doi:10.3109/09273948.2010.509532 · Cited by 17
Anterior Chamber-Associated Immune Deviation
Biros, D. (2008) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2007.12.006 · Cited by 17
Safety Evaluation of Ocular Drugs
Attar, M., Brassard, J. A., Kim, A. S., Matsumoto, S. S., Ramos, M. F., & Vangyi, C. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-387815-1.00024-1 · Cited by 18
Bussing, D., Li, Z., Li, Y., Chang, H.-P., Chang, H.-Y., Guo, L., Verma, A., & Shah, D. K. (2021) · The AAPS Journal · doi:10.1208/s12248-021-00647-0 · Cited by 16
Vashishtha, A., Maina, S., Altman, J., Jones, G., Lee, T. J., Bollinger, K. E., Ulrich, L., Töteberg‐Harms, M., Estes, A. J., Zhi, W., et al. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13091400 · Cited by 17
“The ocular environment exhibits a unique combination of immunosuppressive and anti-inflammatory characteristics referred to as ocular immune privilege [1,2].”
BackgroundBiomaterial-assisted strategies to improve islet graft revascularization and transplant outcomes
Qi, B., Ding, Y., Zhang, Y., Kou, L., Zhao, Y., & Yao, Q. (2024) · Biomaterials Science · doi:10.1039/d3bm01295f · Cited by 18
ABCB1 transporter and Toll-like receptor 4 in trabecular meshwork cells.
Grybauskas, A., Koga, T., Kuprys, P. V., Nolan, M. J., McCarty, R. D., Walker, L., Green, K. A., Norkett, W. M., Yue, B. Y. J. T., & Knepper, P. A. (2015) · PubMed Central · Cited by 15
Sugita, S., Horie, S., Yamada, Y., Keino, H., Usui, Y., Takeuchi, M., & Mochizuki, M. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4460 · Cited by 16
Ling, D., Liu, B., Jawad, S., Thompson, I., Nagineni, C. N., Dailey, J., Chien, J. L., Sredni, B., & Nussenblatt, R. B. (2013) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2012-301962 · Cited by 16
Mo, J., Neelam, S., Mellon, J., Brown, J. R., & Niederkorn, J. Y. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-20601 · Cited by 16
Toda, M., Yukawa, H., Yamada, J., Ueno, M., Kinoshita, S., Baba, Y., & Hamuro, J. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.19-27788 · Cited by 16
“In the clinical setting, we have observed no immune response to allogenic CECs during the follow-up period, and previous murine studies have indicated the induction of immune tolerance in the eye against the injected allogenic CECs(36) and the AC-associated immune deviation (ACAID) of the eye.(43) In this present stud…”
BackgroundAnimal models of high-risk corneal transplantation: A comprehensive review
Singh, R. B., Marmalidou, A., Amouzegar, A., Chen, Y., & Dana, R. (2020) · Experimental Eye Research · doi:10.1016/j.exer.2020.108152 · Cited by 16
“…of intraocular F4/80-positive antigen-presenting cells (APCs), maintained in an immature state by transforming growth factor (TGF-β2), which capture the antigen at the ocular surface and subsequently migrate via the trabecular meshwork to the spleen, forming a camero-splenic axis (Streilein, 2003).”
BackgroundEye on the Enigmatic Link: Dysbiotic Oral Pathogens in Ocular Diseases; The Flip Side
Arjunan, P. (2020) · International Reviews of Immunology · doi:10.1080/08830185.2020.1845330 · Cited by 17
“is shown to maintain an immune-privileged state [189,190] like that of the brain, as the entry of”
BackgroundLi, Y., Li, Z., Quan, Y., Cheng, H., Riquelme, M. A., Li, X.-D., Gu, S., & Jiang, J. X. (2021) · iScience · doi:10.1016/j.isci.2021.102533 · Cited by 19
Advancing precision medicines for ocular disorders: Diagnostic genomics to tailored therapies
Panikker, P., Roy, S., Ghosh, A., Poornachandra, B., & Ghosh, A. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.906482 · Cited by 19
“Therefore, the normal inflammatory immune response is limited within the ocular chamber (8) as well as on the ocular surface (9, 10) due to the presence of specific molecular factors in the ocular fluids and expression of immune dampening signals on tissue surfaces that dampen the immune responses locally.”
BackgroundSchöllhorn, L., Bock, F., & Cursiefen, C. (2015) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2015.0020 · Cited by 18
“59,60 Already in 1990 it was shown that TSP-1 regulates migration and proliferation of blood endothelial cells.”
Somatostatin modulates PI3K-Akt, eNOS and NHE activity in the ciliary epithelium
Ghosh, S., Choritz, L., Geibel, J. P., & Coca‐Prados, M. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.05.002 · Cited by 16
Control of Ocular Tumor Growth and Metastatic Spread by Soluble and Membrane Fas Ligand
Gregory, M. S., Saff, R. R., Marshak‐Rothstein, A., & Ksander, B. R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0780 · Cited by 16
“These immune-privileged sites use a variety of mechanisms to regulate innate and adaptive immunity (6, 7).”
BackgroundInterleukin (IL)-17A Promotes Angiogenesis in an Experimental Corneal Neovascularization Model
Liu, G., Wu, H., Lu, P., & Zhang, X. (2016) · Current Eye Research · doi:10.1080/02713683.2016.1196705 · Cited by 17
VISTA Is Crucial for Corneal Allograft Survival and Maintenance of Immune Privilege
Kunishige, T., Taniguchi, H., Ohno, T., Azuma, M., & Hori, J. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.19-27322 · Cited by 17
Nakamura, T., Terajewicz, A., & Stein‐Streilein, J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2643 · Cited by 17
“It is known that there is both an afferent Tr cell and an efferent Tr cell generated following the injection of Ag into the eye (20, 27).”
BackgroundWhole-eye transplantation: Current challenges and future perspectives
Scarabosio, A., Surico, P. L., Tereshenko, V., Singh, R. B., Salati, C., Spadea, L., Caputo, G. G., Parodi, P. C., Gagliano, C., Winograd, J. M., et al. (2024) · World Journal of Transplantation · doi:10.5500/wjt.v14.i2.95009 · Cited by 17
Ru, L., Wu, N., Wei, K., Zeng, Y.-X., Li, Q., Weng, C.-H., Ren, C.-G., Ren, B.-Q., Huo, D., Li, Y.-J., et al. (2020) · Stem cell research & therapeutics · doi:10.1186/s13287-020-01986-z · Cited by 11
Tumors, tumor therapies, autoimmunity and the eye
Wildner, G. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102892 · Cited by 15
Itty, S., Proia, A. D., DelMonte, D. W., Santaella, R. M., Carlson, A. N., & Allingham, R. R. (2014) · Cornea · doi:10.1097/ico.0000000000000234 · Cited by 15
“A mechanism that may be involved is anterior chamber–associated immune deviation, a well-described phenomenon where the host immune system actively induces tolerance to antigens in the anterior chamber.(18) Anterior chamber–associated immune deviation would allow foreign proteins and cells to exist and potentially thr…”
BackgroundKunishige, T., Taniguchi, H., Terada, M., Akiba, H., Yagita∥, H., Abe, R., & Hori, J. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-20644 · Cited by 15
Bacillus spp. as Pathogens in the Dairy Industry
Grutsch, A. A., Nimmer, P. S., Pittsley, R. H., & McKillip, J. L. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811444-5.00007-5 · Cited by 15
Tyrosinase Is a Novel Endogenous Regulator of Developmental and Inflammatory Lymphangiogenesis
Büttner, C., Clahsen, T., Regenfuß, B., Dreisow, M.-L., Steiber, Z., Bock, F., Reis, A., & Cursiefen, C. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.10.014 · Cited by 16
Hara, S., Tsujikawa, M., Maruyama, K., & Nishida, K. (2018) · Experimental Eye Research · doi:10.1016/j.exer.2018.11.008 · Cited by 16
II.D. Hyalocytes: Essential Vitreous Cells in Vitreoretinal Health and Disease
Kita, T., Sakamoto, T., & Ishibashi, T. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1086-1_10 · Cited by 15
Immune Privilege Furnishes a Niche for Latent Infection
Forrester, J. V., Mölzer, C., & Kuffová, L. (2022) · Frontiers in Ophthalmology · doi:10.3389/fopht.2022.869046 · Cited by 20
Intraocular mRNA delivery with endogenous MmPEG10-based virus-like particles
Li, M., Liu, Z., Wang, D., Ye, J., Shi, Z., Pan, C., Zhang, Q., Ju, R., Zheng, Y., & Liu, Y. (2024) · Experimental Eye Research · doi:10.1016/j.exer.2024.109899 · Cited by 16
Clinical Considerations for Vascularized Composite Allotransplantation of the Eye
Davidson, E. H., Wang, E. W., Yu, J. Y., Fernandez-Miranda, J. C., Wang, D. J., Li, Y., Miller, M. R., Sivak, W. N., Bourne, D., Wang, H., et al. (2016) · Journal of Craniofacial Surgery · doi:10.1097/scs.0000000000002985 · Cited by 14
“Nonetheless, the ocular compartments as well as the cornea, retinal pigment epithelium, and neuronal retina function as immune privileged sites that resist immune rejection when implanted as allografts.(35) The potential clinical ramifications for this phenomenon in highlights the need for further research in this are…”
BackgroundIselin, K. C., Greenan, E., Hynes, C., Shaw, S. S., Fulcher, T., Power, W. J., Quill, B., Guerin, M., Lee, W. H., & Murphy, C. C. (2020) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-020-02340-1 · Cited by 14
Immune Inhibitor A Metalloproteases Contribute to Virulence in Bacillus Endophthalmitis
Livingston, E. T., Mursalin, M. H., Coburn, P. S., Astley, R., Miller, F. C., Amayem, O., Lereclus, D., & Callegan, M. C. (2021) · Infection and Immunity · doi:10.1128/iai.00201-21 · Cited by 14
“The immune response in the eye is tightly regulated -- the vitreous is 322 avascular, there is a lack of lymphatic vessels and antigen presenting cells, and immunosuppressive 323 factors are present [45-47].”
BackgroundOral voclosporin: novel calcineurin inhibitor for treatment of noninfectious uveitis
Roesel, M., Tappeiner, Heiligenhaus, & Heinz (2011) · Clinical ophthalmology · doi:10.2147/opth.s11125 · Cited by 15
“intestinal polpeptide, alpha-melanocyte-stimulating hormone, and calcitonin-releasing protein) regulating the activity of leukocytes.(9,10) If ocular immune privilege is broken, the uvea and adjacent tissue are infiltrated and damaged by inflammatory cells.”
Corneal graft rejection occurs despite Fas ligand expression and apoptosis of infiltrating cells
Williams, K. A. (2005) · British Journal of Ophthalmology · doi:10.1136/bjo.2003.040675 · Cited by 14
Phan, C., Bajgrowicz, M., McCanna, D. J., Subbaraman, L. N., & Jones, L. (2015) · Eye & Contact Lens Science & Clinical Practice · doi:10.1097/icl.0000000000000209 · Cited by 14
“As such, the yeasts are not subjected to several growth pressures, such as those from the immune system, which would otherwise be present in an in vivo environment.(38) Furthermore, the current model only provides a qualitative assessment of yeast growth in response to an antifungal delivering CL.”
BackgroundTeixeira, L. B. C., & Dubielzig, R. R. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415759-0.00053-4 · Cited by 15
Matthews, A. G. (2008) · Veterinary Ophthalmology · doi:10.1111/j.1463-5224.2008.00635.x · Cited by 14
Hydroxyurea in Children with Sickle Cell Disease: Practice Patterns and Barriers to Utilization.
Brandow, A. M., Jirovec, D. L., & Panepinto, J. A. (2009) · Blood · doi:10.1182/blood.v114.22.242.242 · Cited by 14
Cross Talk among Cells Promoting Anterior Chamber-Associated Immune Deviation
Stein‐Streilein, J., & Watte, C. M. (2007) · KARGER eBooks · doi:10.1159/000099262 · Cited by 15
Cell Replacement Therapy and the Evasion of Destructive Immunity
Fairchild, P. J., Robertson, N. J., Cartland, S. P., Nolan, K. F., & Waldmann, H. (2005) · Stem Cell Reviews and Reports · doi:10.1385/scr:1:2:159 · Cited by 14
Sphingolipid extracts enhance gene delivery of cationic lipid vesicles into retina and brain
Qtaish, N. A., Gallego, I., Villate-Beitia, I., Sainz-Ramos, M., Martínez, G., Soto‐Sánchez, C., Fernández, E., Gálvez‐Martín, P., López-Méndez, T. B., Puras, G., et al. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.09.011 · Cited by 13
The anterior chamber of the eye technology and its anatomical, optical, and immunological bases
Yang, S.-N., Shi, Y., & Berggren, P. (2024) · Physiological Reviews · doi:10.1152/physrev.00024.2023 · Cited by 14
Carlà, M. M., Gambini, G., Caporossi, T., Giannuzzi, F., Boselli, F., Crincoli, E., Ripa, M., & Rizzo, S. (2024) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2024.2308030 · Cited by 15
“63,64 In the very first reports, no links between SSc and retino-pathy were found.”
Retinoic Acid Potentiates Orbital Tissues for Inflammation Through NF-κB and MCP-1
Unsworth, S. P., Heisel, C. J., Tingle, C. F., Rajesh, N., Kish, P. E., & Kahana, A. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.8.17 · Cited by 13
Wundheilung der Kornea – Pathophysiologie und Grundlagen
Brockmann, T., Walckling, M., Brockmann, C., Fuchsluger, T. A., & Pleyer, U. (2021) · Der Ophthalmologe · doi:10.1007/s00347-021-01423-3 · Cited by 17
Detection of Pro- and Antiangiogenic Factors in the Human Sclera
Schlereth, S. L., Karlstetter, M., Hos, D., Matthaei, M., Cursiefen, C., & Heindl, L. M. (2018) · Current Eye Research · doi:10.1080/02713683.2018.1540704 · Cited by 13
Pe’er, J., Rowe, J. M., Frenkel, S., & Dann, E. J. (2010) · American Journal of Hematology · doi:10.1002/ajh.21767 · Cited by 13
The Host–Pathogen Interplay: A Tale of Two Stories within the Cornea and Posterior Segment
Dempsey, M. P., & Conrady, C. D. (2023) · Microorganisms · doi:10.3390/microorganisms11082074 · Cited by 11
Hu, M., Liu, B., Jawad, S., Ling, D., Casady, M., Wei, L., & Nussenblatt, R. B. (2011) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2011-300235 · Cited by 13
Aqueous outflow channels and its lymphatic association: A review
Narayanaswamy, A., Thakur, S., Nongpiur, M. E., Schmetterer, L. F., Hong, Y., Huang, A. S., & Wong, T. T. L. (2021) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2021.10.004 · Cited by 11
Advances in transcorneal electrical stimulation: From the eye to the brain
Agadagba, S. K., Lim, L. W., & Chan, L. L. H. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1134857 · Cited by 14
“The eyes contain several immunoregulatory molecules including cytokines and other surface molecules ( Figure 2C ) that induce specialized immune responses similar to those of neurons in the brain and spinal cord (Streilein, 2003; Kaur et al., 2008).”
BackgroundRetina stem cells, hopes and obstacles
German, O. L., Vallese-Maurizi, H., Soto, T. B., Rotstein, N. P., & Politi, L. E. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i10.1446 · Cited by 13
Funatsu, H., Yamashita, T., & Yamashita, H. (2006) · Advances in clinical chemistry · doi:10.1016/s0065-2423(06)42004-7 · Cited by 13
Prolongation of corneal xenotransplant survival by T‐cell vaccination‐induced T‐regulatory cells
Wang, J., Jiang, S., Shi, H., Lin, Y. C., Wang, J., & Wang, X. (2008) · Xenotransplantation · doi:10.1111/j.1399-3089.2008.00471.x · Cited by 12
“Immune privilege results from anatomic and biochemical factors that cooperate to down-regulate the induction and expression of immune responses [1,2].”
BackgroundACAID as a potential therapeutic approach to modulate inflammation in neurodegenerative diseases
Toscano-Tejeida, D., Ibarra, A., Phillips-Farfán, B. V., Fuentes-Farías, A. L., & Meléndez‐Herrera, E. (2016) · Medical Hypotheses · doi:10.1016/j.mehy.2016.01.006 · Cited by 12
The Function of the Retinal Pigment Epithelium
Strauß, O., & Helbig, H. (2011) · Elsevier eBooks · doi:10.1016/b978-0-323-05714-1.00013-3 · Cited by 14
Maintenance of Immune Tolerance Depends on Normal Tissue Homeostasis
Boonman, Z., van Mierlo, G. V., Fransen, M., de Keizer, R. D., Jager, M., Melief, C., & Toes, R. (2005) · Journal of Immunology · doi:10.4049/jimmunol.175.7.4247 · Cited by 16
The Mouse Cornea as a Transplantation Site for Live Imaging of Engineered Tissue ConstructsPreprint
Poché, R. A., Saik, J. E., West, J. L., & Dickinson, M. E. (2010) · Cold Spring Harbor Protocols · doi:10.1101/pdb.prot5416 · Cited by 12
“Another major advantage of this system is that the cornea is a relatively immune privileged site (Streilein 2003a,b).”
BackgroundThe low-density lipoprotein receptor-related protein 1 (LRP1) interactome in the human cornea
Mogensen, E. H., Poulsen, E. T., Thøgersen, I. B., Yamamoto, K., Brüel, A., & Enghild, J. J. (2022) · Experimental Eye Research · doi:10.1016/j.exer.2022.109081 · Cited by 11
Caielli, S., Sorini, C., & Falcone, M. (2010) · Autoimmunity · doi:10.3109/08916931003782130 · Cited by 12
“Excessive intraocular inflammation is avoided by a process known as anterior chamber-associated immune deviation (ACAID)—a process that also has the ability to induce peripheral tolerance to antigens in the vitreous cavity or in the subretinal space [22–24].”
BackgroundInhibitory effect of corneal endothelial cells on IL-17-producing Th17 cells
Sugita, S., Kawazoe, Y., Yamada, Y., Imai, A., Horie, S., Yamagami, S., & Mochizuki, M. (2011) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2011-300769 · Cited by 11
“INTRODUCTION Ocular immune privilege has raised interest in the local mechanisms of immune tolerance.(1) Corneal endothelial (CE) cells form part of the boundaries of the anterior chamber, an immune-privileged site, and could contribute to that immune privilege.”
BackgroundNew Aspects of Angiogenesis in the Cornea
Cursiefen, C., & Kruse, F. E. (2006) · Essentials in ophthalmology/Essentials ophthalmology · doi:10.1007/3-540-31226-9_7 · Cited by 11
“Therefore, in all higher animals depending on good vision, the cornea normally is devoid of blood and lymphatic vessels [12, 13, 21, 30 ].”
BackgroundInfluentialTao, T., Liu, Y., Zhang, J., Huang, L., & Tao, Y. (2022) · Ophthalmic Research · doi:10.1159/000524485 · Cited by 13
Inhibition of corneal inflammation following keratoplasty by birch leaf extract
Wacker, K., Gründemann, C., Kern, Y., Bredow, L., Huber, R., Reinhard, T., & Schwartzkopff, J. (2012) · Experimental Eye Research · doi:10.1016/j.exer.2012.01.004 · Cited by 11
Accelerated corneal graft rejection in baby rats
Schwartzkopff, J., Berger, M., Birnbaum, F., Böhringer, D., & Reinhard, T. (2009) · British Journal of Ophthalmology · doi:10.1136/bjo.2008.154435 · Cited by 11
“In short, Streilein and others showed that the excellent survival rates following keratoplasty are a consequence of the immune privileged status of the cornea and the eye itself.(6) 7 Our group proposed an animal model for keratoplasty in baby rats to address this problem in the young.”
BackgroundControl of the retinal local RAS by the RPE: An interface to systemic RAS activity
Reichhart, N., Figura, A., Skosyrski, S., & Strauß, O. (2019) · Experimental Eye Research · doi:10.1016/j.exer.2019.107838 · Cited by 11
Immune Privilege of Corneal Allografts
Niederkorn, J. Y. (2010) · Essentials in ophthalmology/Essentials ophthalmology · doi:10.1007/978-3-540-85544-6_1 · Cited by 11
Concept of Angiogenic Privilege
Regenfuß, B., & Cursiefen, C. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374203-2.00121-4 · Cited by 11
Immunology in corneal transplantation—From homeostasis to graft rejection
Lee, S.-J., Dohlman, T. H., & Dana, R. (2025) · Transplantation Reviews · doi:10.1016/j.trre.2025.100909 · Cited by 10
Immunology and Pathology in Ocular Drug Development
Ramos, M. F., Brassard, J. A., & Masli, S. (2021) · Toxicologic Pathology · doi:10.1177/0192623320978396 · Cited by 12
“Therefore, while some interacting components of IP are dispensable, the loss of certain critical factors, as indicated in Table 2, will destabilize the balanced mechanisms that maintain IP resulting in complete loss of IP.”
BackgroundInfluentialGregory-Ksander, M. S., & Marshak‐Rothstein, A. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ri1220-834r · Cited by 12
Karpenko, D. V., Михайлович, К. Н., & Bigildeev, A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.993056 · Cited by 12
“IPs in tissues and organs provide suppression of inflammation and promote immune tolerance to the whole organ resulting in the protection of the whole transplant, given allogenic transplantation have been made (Streilein 2003; Hill et al., 2021).”
BackgroundLosing, preserving, and restoring vision from neurodegeneration in the eye
Kerschensteiner, D. (2023) · Current Biology · doi:10.1016/j.cub.2023.08.044 · Cited by 12
“Gene therapy Monogenic inheritance, the accessibility of the retina in the eye, and its immune privilege make IRDs promising targets for gene therapies 129,130 .”
BackgroundAscorbate in Aqueous Humor Augments Nitric Oxide Production by Macrophages
McKenna, K. C., Beatty, K. M., Scherder, R. C., Li, F., Liu, H., Chen, A. F., Ghosh, A., & Stuehr, D. J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201754 · Cited by 10
“However, these immune responses can also pose a threat to vision if uncontrolled inflammation damages tissues that do not regenerate (1, 2).”
BackgroundGraybill, C., Claypool, D. J., Brinton, J. T., Levin, M. J., & Lee, K. S. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix426 · Cited by 10
Immune Mediators against Toxoplasma Gondii during Reactivation of Toxoplasmic Retinochoroiditis
Rudzinski, M. N., Argüelles, C. F., Couto, C. A., Oubiña, J. R., & Reina, S. (2018) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2018.1499940 · Cited by 10
Aqueous humor induces lymphatic regression on the ocular surface
Shi, M., Zhang, L., Ye, E.-A., Wang, A., Li, G., & Chen, L. (2020) · The Ocular Surface · doi:10.1016/j.jtos.2020.03.002 · Cited by 10
Coaxing the liver into preventing autoimmune disease in the brain
Hoffman, B. E., & Herzog, R. W. (2008) · Journal of Clinical Investigation · doi:10.1172/jci37079 · Cited by 12
Metadata
- Authors
- Streilein, J. W.
- Affiliations
- Harvard University (US)
- Corresponding author
- Streilein, J. Wayne
- Venue
- Nature Reviews Immunology
- Published
- 2003-11
- Volume
- 3
- Issue
- 11
- Pages
- 879-889
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2166550261
- Cited by
- 807
- References
- 125
- Citations by year
- 2026: 33 · 2025: 33 · 2024: 40 · 2023: 31 · 2022: 43 · 2021: 54 · 2020: 46 · 2019: 31 · 2018: 33 · 2017: 44 · 2016: 39 · 2015: 34 · 2014: 28 · 2013: 31 · 2012: 37
- FWCI
- 5.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Keywords
- ocular immune privilege, eye, intraocular inflammation, vision loss, autoimmune eye disease, corneal transplantation, allograft acceptance, corneal immunology
- MeSH terms
- Animals, Autoimmune Diseases, Eye, Eye Diseases, Humans, Immunity, Inflammation, Transplantation, Homologous
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.